Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Papillomavirus Infections 7Uterine Cervical Neoplasms 5Neuroendocrine Tumors 4Neoplasms 4Autoimmune Diseases 3Ovarian Neoplasms 2Myasthenia Gravis 2Mesothelioma, Malignant 2Lung Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Dysplasia 1Thyroid Diseases 1Thrombosis 1Squamous Intraepithelial Lesions 1Retinal Telangiectasis 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Hairy Cell 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 33pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Data Collection × Clear all
NCT02312960 2025-03-25

Radium-223 Dichloride Long-term Follow-up Program

Bayer

Phase 4 Completed
255 enrolled 31 charts
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡